<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39335714</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4418</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>18</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Diagnostics (Basel, Switzerland)</Title><ISOAbbreviation>Diagnostics (Basel)</ISOAbbreviation></Journal><ArticleTitle>The Role of the Basophil Activation Test in the Diagnosis of Drug-Induced Anaphylaxis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2036</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/diagnostics14182036</ELocationID><Abstract><AbstractText>The diagnosis of drug-induced anaphylaxis (DIA) is a serious health problem. The Basophil activation test (BAT) is considered a specific in vitro provocation, and compared to in vivo provocation, it is more convenient, cheaper, and safer for the patient. This study aimed to evaluate the usefulness of the BAT in the diagnosis of DIA. This study included 150 patients referred to a reference allergy clinic with suspected drug allergies. All patients underwent a detailed clinical evaluation supplemented with the BAT. Positive BAT results were obtained in two out of 21 patients who were to receive the COVID-19 vaccine. The sensitivity and specificity of the BAT were 40% and 75% for the COVID-19 vaccine, 67% and 58% for DMG PEG 2000, and 100% and 75% for PEG 4000, respectively. Nine out of 34 patients with suspected antibiotic allergies had positive BAT results with 14 different antibiotics. Positive BAT results were also obtained with NSAIDs in two patients and with local anesthetics in three patients. The confirmation of allergy by the BAT improves the safety profile of the diagnostic work-up as it may defer the need for drug provocation, preventing potential anaphylactic reactions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Czarnobilska</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathophysiology, Jagiellonian University Medical College, Czysta St. 18, 31-121 Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bulanda</LastName><ForeName>Małgorzata</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6023-260X</Identifier><AffiliationInfo><Affiliation>Department of Clinical and Environmental Allergology, Jagiellonian University Medical College, Botaniczna St. 3, 31-501 Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Czarnobilska</LastName><ForeName>Ewa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Clinical and Environmental Allergology, Jagiellonian University Medical College, Botaniczna St. 3, 31-501 Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dyga</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-5689-4803</Identifier><AffiliationInfo><Affiliation>Department of Clinical and Environmental Allergology, Jagiellonian University Medical College, Botaniczna St. 3, 31-501 Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazur</LastName><ForeName>Marcel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7721-2883</Identifier><AffiliationInfo><Affiliation>Department of Clinical and Environmental Allergology, Jagiellonian University Medical College, Botaniczna St. 3, 31-501 Krakow, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>N41/DBS/000988</GrantID><Agency>Jagiellonian University</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diagnostics (Basel)</MedlineTA><NlmUniqueID>101658402</NlmUniqueID><ISSNLinking>2075-4418</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">in vitro test</Keyword><Keyword MajorTopicYN="N">severe allergic reactions</Keyword><Keyword MajorTopicYN="N">vaccines</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39335714</ArticleId><ArticleId IdType="pmc">PMC11430944</ArticleId><ArticleId IdType="doi">10.3390/diagnostics14182036</ArticleId><ArticleId IdType="pii">diagnostics14182036</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cardona V., Ansotegui I.J., Ebisawa M., El-Gamal Y., Fernandez Rivas M., Fineman S., Geller M., Gonzalez-Estrada A., Greenberger P.A., Sanchez Borges M., et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ. J. 2020;13:100472. doi: 10.1016/j.waojou.2020.100472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.waojou.2020.100472</ArticleId><ArticleId IdType="pmc">PMC7607509</ArticleId><ArticleId IdType="pubmed">33204386</ArticleId></ArticleIdList></Reference><Reference><Citation>Muraro A., Worm M., Alviani C., Cardona V., DunnGalvin A., Garvey L.H., Riggioni C., de Silva D., Angier E., Arasi S., et al. EAACI guidelines: Anaphylaxis (2021 update) Allergy. 2022;77:357. doi: 10.1111/all.15032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15032</ArticleId><ArticleId IdType="pubmed">34343358</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodríguez-Pérez R., de las Vecillas L., Cabañas R., Bellón T. Tools for Etiologic Diagnosis of Drug-Induced Allergic Conditions. Int. J. Mol. Sci. 2023;24:12577. doi: 10.3390/ijms241612577.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241612577</ArticleId><ArticleId IdType="pmc">PMC10454098</ArticleId><ArticleId IdType="pubmed">37628756</ArticleId></ArticleIdList></Reference><Reference><Citation>Blazowski L., Majak P., Kurzawa R., Kuna P., Jerzynska J. A severity grading system of food-induced acute allergic reactions to avoid the delay of epinephrine administration. Ann. Allergy Asthma Immunol. 2021;127:462. doi: 10.1016/j.anai.2021.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2021.04.015</ArticleId><ArticleId IdType="pubmed">33895419</ArticleId></ArticleIdList></Reference><Reference><Citation>Ring J., Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;1:466. doi: 10.1016/S0140-6736(77)91953-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(77)91953-5</ArticleId><ArticleId IdType="pubmed">65572</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallardy M., Bechara R., Whritenour J., Mitchell-Ryan S., Herzyk D., Lebrec H., Merk H., Gourley I., Komocsar W.J., Piccotti J.R., et al. Drug hypersensitivity reactions: Review of the state of the science for prediction and diagnosis. Toxicol. Sci. 2024;200:11–30. doi: 10.1093/toxsci/kfae046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfae046</ArticleId><ArticleId IdType="pmc">PMC11199923</ArticleId><ArticleId IdType="pubmed">38588579</ArticleId></ArticleIdList></Reference><Reference><Citation>Castells M. Diagnosis and management of anaphylaxis in precision medicine. J. Allergy Clin. Immunol. 2017;140:321. doi: 10.1016/j.jaci.2017.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.06.012</ArticleId><ArticleId IdType="pubmed">28780940</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos A.F., Alpan O., Hoffmann H.J. Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice. Allergy. 2021;76:2420. doi: 10.1111/all.14747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14747</ArticleId><ArticleId IdType="pubmed">33475181</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahri R., Custovic A., Korosec P., Tsoumani M., Barron M., Wu J., Sayers R., Weimann A., Ruiz-Garcia M., Patel N., et al. Mast cell activation test in the diagnosis of allergic disease and anaphylaxis. J. Allergy Clin. Immunol. 2018;142:485–496.e16. doi: 10.1016/j.jaci.2018.01.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.01.043</ArticleId><ArticleId IdType="pmc">PMC6075471</ArticleId><ArticleId IdType="pubmed">29518421</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States 2021.  [(accessed on 1 April 2024)]; Available online:  https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html.</Citation></Reference><Reference><Citation>Bujang M.A. An elaboration on sample size determination for correlations based on effect sizes and confidence interval width: A guide for researchers. Restor. Dent. Endod. 2024;49:e21. doi: 10.5395/rde.2024.49.e21.</Citation><ArticleIdList><ArticleId IdType="doi">10.5395/rde.2024.49.e21</ArticleId><ArticleId IdType="pmc">PMC11148401</ArticleId><ArticleId IdType="pubmed">38841381</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanschmann T., Francuzik W., Dölle-Bierke S., Hofmeier K.S., Grabenhenrich L., Ruëff F., Renaudin J.M., Pföhler C., Treudler R., Bilò M.B., et al. Different phenotypes of drug-induced anaphylaxis-Data from the European Anaphylaxis Registry. Allergy. 2023;78:1615. doi: 10.1111/all.15612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15612</ArticleId><ArticleId IdType="pubmed">36479710</ArticleId></ArticleIdList></Reference><Reference><Citation>Koumaki D., Gregoriou S., Evangelou G., Katoulis A., Papadakis M., Krueger-Krasagakis S.E., Doxastaki A., Mylonakis D., Krasagakis K. Real-Life Utility of Basophil Activation Test in the Diagnosis of Immediate Hypersensitivity Drug Reactions. Dermatol. Ther. 2023;13:3229. doi: 10.1007/s13555-023-01069-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13555-023-01069-w</ArticleId><ArticleId IdType="pmc">PMC10689598</ArticleId><ArticleId IdType="pubmed">38015412</ArticleId></ArticleIdList></Reference><Reference><Citation>Furman K., Kasprzyk-Wieczorkowska E., Glück J., Gawlik R. Bezpieczeństwo szczepienia przeciw COVID-19 wśród pacjentów po przebytych reakcjach alergicznych. Alergol. Pol. Pol. J. Allergol. 2023;10:41. doi: 10.5114/pja.2023.125767.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/pja.2023.125767</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbaud A., Garvey L.H., Arcolaci A., Brockow K., Mori F., Mayorga C., Bonadonna P., Atanaskovic-Markovic M., Moral L., Zanoni G., et al. Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper. Allergy. 2022;77:2292. doi: 10.1111/all.15241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15241</ArticleId><ArticleId IdType="pubmed">35112371</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruszewski J., Cichocka-Jarosz E., Czarnobilska E., Jutel M., Kulus M., Kuna P., Kupczyk M., Niedoszytko M., Nittner-Marszalska M., Pałczyński C., et al. Rekomendacje Polskiego Towarzystwa Alergologicznego dotyczące kwalifikacji osób z alergią i anafilaksją do szczepienia przeciw COVID-19. Alergol. Pol. Pol. J. Allergol. 2021;8:1. doi: 10.5114/pja.2021.104220.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/pja.2021.104220</ArticleId></ArticleIdList></Reference><Reference><Citation>Blumenthal K.G., Robinson L.B., Camargo C.A., Shenoy E.S., Banerji A., Landman A.B., Wickner P. Acute allergic reactions to mRNA COVID-19 vaccines. JAMA. 2021;325:1562. doi: 10.1001/jama.2021.3976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3976</ArticleId><ArticleId IdType="pmc">PMC7941251</ArticleId><ArticleId IdType="pubmed">33683290</ArticleId></ArticleIdList></Reference><Reference><Citation>Czarnobilska M., Bulanda M., Kurnik-Łucka M., Gil K. Hypersensitivity to polyethylene glycol (PEG) Folia Med. Cracov. 2021;61:55. doi: 10.24425/fmc.2021.140004.</Citation><ArticleIdList><ArticleId IdType="doi">10.24425/fmc.2021.140004</ArticleId><ArticleId IdType="pubmed">35180202</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellaturay P., Nasser S., Ewan P. Polyethylene Glycol-Induced Systemic Allergic Reactions (Anaphylaxis) Allergy Clin. Immunol. Pract. 2021;9:670. doi: 10.1016/j.jaip.2020.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2020.09.029</ArticleId><ArticleId IdType="pubmed">33011299</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren C.M., Snow T.T., Lee A.S., Shah M.M., Heider A., Blomkalns A., Betts B., Buzzanco A.S., Gonzalez J., Chinthrajah R.S., et al. Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system. JAMA Netw. Open. 2021;4:e2125524. doi: 10.1001/jamanetworkopen.2021.25524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.25524</ArticleId><ArticleId IdType="pmc">PMC8449279</ArticleId><ArticleId IdType="pubmed">34533570</ArticleId></ArticleIdList></Reference><Reference><Citation>Eberlein B., Mathes S., Fischer J., Darsow U., Biedermann T., Brockow K. Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines? Allergy. 2022;77:2924. doi: 10.1111/all.15278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15278</ArticleId><ArticleId IdType="pmc">PMC9111482</ArticleId><ArticleId IdType="pubmed">35266570</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockow K., Mathes S., Fischer J., Volc S., Darsow U., Eberlein B., Biedermann T. Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis. Allergy. 2022;77:2200. doi: 10.1111/all.15183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15183</ArticleId><ArticleId IdType="pmc">PMC9011687</ArticleId><ArticleId IdType="pubmed">34806775</ArticleId></ArticleIdList></Reference><Reference><Citation>Labella M., Céspedes J.A., Doña I., Shamji M.H., Agache I., Mayorga C., Torres M.J. The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine. Allergy. 2022;77:2067. doi: 10.1111/all.15148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15148</ArticleId><ArticleId IdType="pmc">PMC8653141</ArticleId><ArticleId IdType="pubmed">34689351</ArticleId></ArticleIdList></Reference><Reference><Citation>Vespa S., Del Biondo P., Simeone P., Cavallucci E., Catitti G., Auciello R., De Bellis D., Altomare I., Pierdomenico L., Canonico B., et al. Basophil Activation Test with Different Polyethylene Glycols in Patients with Suspected PEG Hypersensitivity Reactions. Int. J. Mol. Sci. 2022;23:14592. doi: 10.3390/ijms232314592.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232314592</ArticleId><ArticleId IdType="pmc">PMC9740962</ArticleId><ArticleId IdType="pubmed">36498922</ArticleId></ArticleIdList></Reference><Reference><Citation>Restivo V., Candore G., Barrale M., Caravello E., Graziano G., Onida R., Raineri M., Tiralongo S., Brusca I. Allergy to polyethylene glycol of anti-SARS CoV2 vaccine recipient: A case report of young adult recipient and the management of future exposure to SARS-CoV2. Vaccines. 2021;9:412. doi: 10.3390/vaccines9050412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9050412</ArticleId><ArticleId IdType="pmc">PMC8143141</ArticleId><ArticleId IdType="pubmed">33919151</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok M., Lack G., Santos A.F. Improved standardisation of the whole blood basophil activation test to peanut. Clin. Transl. Allergy. 2017;8((Suppl. S2)):15–16.</Citation></Reference><Reference><Citation>Sturm G.J., Kranzelbinder B., Sturm E.M., Heinemann A., Groselj-Strele A., Aberer W. The basophil activation test in the diagnosis of allergy: Technical issues and critical factors. Allergy. 2009;64:1319–1326. doi: 10.1111/j.1398-9995.2009.02004.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1398-9995.2009.02004.x</ArticleId><ArticleId IdType="pubmed">19243362</ArticleId></ArticleIdList></Reference><Reference><Citation>Adkinson N.F. A guide to skin testing for penicillin allergy. Med. Times. 1976;104:164.</Citation><ArticleIdList><ArticleId IdType="pubmed">979575</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeimy S., Ben-Shoshan M., Abrams E.M., Ellis A.K., Connors L., Wong T. Practical guide for evaluation and management of beta-lactam allergy: Position statement from the Canadian Society of Allergy and Clinical Immunology. Allergy Asthma Clin. Immunol. 2020;16:95. doi: 10.1186/s13223-020-00494-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13223-020-00494-2</ArticleId><ArticleId IdType="pmc">PMC7653726</ArticleId><ArticleId IdType="pubmed">33292466</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiriac A.M., Vasconcelos M.J., Izquierdo L., Ferrando L., Nahas O., Demoly P. To challenge or not to challenge: Literature data on the positive predictive value of skin tests to beta-lactams. J. Allergy Clin. Immunol. Pract. 2019;7:2404. doi: 10.1016/j.jaip.2019.01.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2019.01.060</ArticleId><ArticleId IdType="pubmed">30844483</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres M.J., Padial A., Mayorga C., Fernandez T., Sanchez-Sabate E., Cornejo-Garcia J.A., Antunez C., Blanca M. The diagnostic interpretation of basophil activation test in immediate allergic reactions to beta-lactams. Clin. Exp. Allergy. 2004;34:1768. doi: 10.1111/j.1365-2222.2004.02110.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2222.2004.02110.x</ArticleId><ArticleId IdType="pubmed">15544603</ArticleId></ArticleIdList></Reference><Reference><Citation>Thinnes A., Merk H.F., Wurpts G., Röseler S., Lehmann S., Tenbrock K., Baron J.M., Balakirski G. Individual risk assessment in the diagnosis of immediate type drug hypersensitivity reactions to betalactam and non-betalactam antibiotics using basophil activation test: A single center experience. Cutan. Ocul. Toxicol. 2018;37:309. doi: 10.1080/15569527.2018.1448990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15569527.2018.1448990</ArticleId><ArticleId IdType="pubmed">29508626</ArticleId></ArticleIdList></Reference><Reference><Citation>De Weck A.L., Sanz M.L., Gamboa P.M., Aberer W., Sturm G., Bilo M.B., Montroni M., Blanca M., Torres M.J., Mayorga L., et al. Diagnosis of immediate-type beta-lactam allergy in vitro by flowcytometric basophil activation test (BAT alias FLOW-CAST) and sulfidoleukotriene production (CAST-ELISA): A multicentric study. J. Investig. Allergol. Clin. Immunol. 2009;19:91.</Citation><ArticleIdList><ArticleId IdType="pubmed">19476013</ArticleId></ArticleIdList></Reference><Reference><Citation>Uyttebroek A., Sabato V., Cop N., Decuyper I., Faber M., Bridts C., Mertens C., Hagendorens M., De Clerck L., Ebo D. Diagnosing cefazolin hypersensitivity: Lessons from dual-labeling flow cytometry. J. Allergy Clin. Immunol. Pract. 2016;4:1243. doi: 10.1016/j.jaip.2016.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2016.08.016</ArticleId><ArticleId IdType="pubmed">27836066</ArticleId></ArticleIdList></Reference><Reference><Citation>Céspedes J.A., Fernández-Santamaría R., Ariza A., Bogas G., Doña I., Rondón C., Salas M., Labella M., Frecha C., Mayorga C., et al. Diagnosis of immediate reactions to amoxicillin: Comparison of basophil activation markers CD63 and CD203c in a prospective study. Allergy. 2023;78:2745. doi: 10.1111/all.15610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15610</ArticleId><ArticleId IdType="pubmed">36478407</ArticleId></ArticleIdList></Reference><Reference><Citation>Blumenthal K.G., Peter J.G., Trubiano J.A., Phillips E.J. Antibiotic allergy. Lancet. 2019;393:183. doi: 10.1016/S0140-6736(18)32218-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)32218-9</ArticleId><ArticleId IdType="pmc">PMC6563335</ArticleId><ArticleId IdType="pubmed">30558872</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner M., Harrer A., Himly M. Basophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions—Potential and Limitations. Front. Pharmacol. 2016;7:171. doi: 10.3389/fphar.2016.00171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2016.00171</ArticleId><ArticleId IdType="pmc">PMC4911350</ArticleId><ArticleId IdType="pubmed">27378928</ArticleId></ArticleIdList></Reference><Reference><Citation>Marraccini P., Pignatti P., D Apos Alcamo A., Salimbeni R., Consonni D. Basophil Activation Test Application in Drug Hypersensitivity Diagnosis: An Empirical Approach. Int. Arch. Allergy Immunol. 2018;177:160. doi: 10.1159/000490116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000490116</ArticleId><ArticleId IdType="pubmed">30045029</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo J., Gong R., Liu X., Zhao J. Risk of True Allergy to Local Anesthetics: 10-Year Experience from an Anesthesia Allergy Clinic in China. Ther. Clin. Risk Manag. 2020;16:1297–1303. doi: 10.2147/TCRM.S280259.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TCRM.S280259</ArticleId><ArticleId IdType="pmc">PMC7778381</ArticleId><ArticleId IdType="pubmed">33402824</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>